Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study
暂无分享,去创建一个
M. Joner | J. Escaned | R. Waksman | R. J. van der Schaaf | J. Iglesias | M. Wiemer | M. Haude | J. Torzewski | P. Vermeersch | J. Bennett | R. Toelg | B. Ferdinande | A. Włodarczak | G. Toth | G. Olivecrona | H. García-García | Gabor Toth | R. Waksman